AACR Immuno-Oncology Conference

Biointron is pleased to announce our attendance at the AACR Immuno-Oncology Conference 2026, a leading scientific forum dedicated to advancing cancer immunology and immunotherapy research, taking place this February 18 - 21, 2026 in Los Angeles, California. Organized by the American Association for Cancer Research, this conference convenes top scientists, clinicians, and industry innovators to explore emerging discoveries that are shaping the future of immuno-oncology. 

The AACR Immuno-Oncology Conference 2026 will spotlight cutting-edge research spanning immune mechanisms in cancer, novel immunotherapeutic strategies, biomarker-driven approaches, and translational pathways from bench to clinic.  

As a dedicated partner in antibody discovery, engineering, and biologics development, Biointron looks forward to engaging with the immuno-oncology community, exchanging insights with experts at the forefront of the field, and supporting innovation that drives the next generation of cancer immunotherapies. 

We look forward to connecting with you at AACR Immuno-Oncology Conference 2026 at booth #210 and contributing to conversations that are advancing the science of cancer immunotherapy. 

For more details about the event, please visit the AACR Immuno-Oncology Conference website [https://www.aacr.org/meeting/aacr-io-2026/] 

Time: February 18 - 21, 2026 

Location: JW Marriott | Los Angeles, California 

Booth: #210